ScoreWhy is Double Medical Technology, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.52% and Operating profit at -2.29% over the last 5 years
2
The company has declared Positive results for the last 9 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 879.91 MM
- NET SALES(9M) At CNY 2,031.92 MM has Grown at 18.01%
- ROCE(HY) Highest at 18.59%
3
With ROE of 17.21%, it has a fair valuation with a 3.78 Price to Book Value
- Over the past year, while the stock has generated a return of 26.17%, its profits have risen by 50.9% ; the PEG ratio of the company is 0.4
- At the current price, the company has a high dividend yield of 0
4
Market Beating performance in long term as well as near term
- Along with generating 26.17% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Double Medical Technology, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Double Medical Technology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Double Medical Technology, Inc.
-20.43%
1.59
39.36%
China Shanghai Composite
3.0%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.52%
EBIT Growth (5y)
-2.29%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.58
Tax Ratio
12.72%
Dividend Payout Ratio
40.70%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.08%
ROE (avg)
13.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
4.65
EV to EBIT
25.35
EV to EBITDA
19.68
EV to Capital Employed
6.99
EV to Sales
5.90
PEG Ratio
0.53
Dividend Yield
NA
ROCE (Latest)
27.58%
ROE (Latest)
17.21%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 848.32 MM
ROCE(HY)
Highest at 21.28%
INTEREST COVERAGE RATIO(Q)
Highest at 24,487.68
OPERATING PROFIT(Q)
Highest at CNY 245.5 MM
RAW MATERIAL COST(Y)
Fallen by -3.97% (YoY
CASH AND EQV(HY)
Highest at CNY 3,697.24 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -41.69 %
EPS(Q)
Highest at CNY 0.5
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Double Medical Technology, Inc.
Operating Cash Flow
Highest at CNY 848.32 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Interest Coverage Ratio
Highest at 24,487.68
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Profit
Highest at CNY 245.5 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (CNY MM)
EPS
Highest at CNY 0.5
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Cash and Eqv
Highest at CNY 3,697.24 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -41.69 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -3.97% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
